Cryptosporidium parvum infection in SCID mice infected with only one oocyst: qPCR assessment of parasite replication in tissues and development of digestive cancer

Sadia Benamrouz, Karine Guyot, Sophie Gazzola, Anthony Mouray, Thierry Chassat, Baptiste Delaire, Magali Chabé, Pierre Gosset, Eric Viscogliosi, Eduardo Dei-Cas, Colette Creusy, Valerie Conseil, Gabriela Certad, Sadia Benamrouz, Karine Guyot, Sophie Gazzola, Anthony Mouray, Thierry Chassat, Baptiste Delaire, Magali Chabé, Pierre Gosset, Eric Viscogliosi, Eduardo Dei-Cas, Colette Creusy, Valerie Conseil, Gabriela Certad

Abstract

Dexamethasone (Dex) treated Severe Combined Immunodeficiency (SCID) mice were previously described as developing digestive adenocarcinoma after massive infection with Cryptosporidium parvum as soon as 45 days post-infection (P.I.). We aimed to determine the minimum number of oocysts capable of inducing infection and thereby gastrointestinal tumors in this model. Mice were challenged with calibrated oocyst suspensions containing intended doses of: 1, 10, 100 or 10(5) oocysts of C. parvum Iowa strain. All administered doses were infective for animals but increasing the oocyst challenge lead to an increase in mice infectivity (P = 0.01). Oocyst shedding was detected at 7 days P.I. after inoculation with more than 10 oocysts, and after 15 days in mice challenged with one oocyst. In groups challenged with lower inocula, parasite growth phase was significantly higher (P = 0.005) compared to mice inoculated with higher doses. After 45 days P.I. all groups of mice had a mean of oocyst shedding superior to 10,000 oocyst/g of feces. The most impressive observation of this study was the demonstration that C. parvum-induced digestive adenocarcinoma could be caused by infection with low doses of Cryptosporidium, even with only one oocyst: in mice inoculated with low doses, neoplastic lesions were detected as early as 45 days P.I. both in the stomach and ileo-caecal region, and these lesions could evolve in an invasive adenocarcinoma. These findings show a great amplification effect of parasites in mouse tissues after challenge with low doses as confirmed by quantitative PCR. The ability of C. parvum to infect mice with one oocyst and to develop digestive adenocarcinoma suggests that other mammalian species including humans could be also susceptible to this process, especially when they are severely immunocompromised.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Pattern of oocyst shedding (oocyst/g…
Figure 1. Pattern of oocyst shedding (oocyst/g feces) of Dex-treated SCID mice.
Experimental groups were inoculated with intended doses of 1, 10, 100 and 105 oocysts. Each point represents one mouse, the lines being the geometric means of oocyst shedding per group. Only animals with oocyst shedding at a precise moment of the day are represented. None of mice infected with one oocyst released parasites until day 15 (see material and methods for oocyst shedding assessment).
Figure 2. Gastro-intestinal neoplastic lesions in Dex-treated…
Figure 2. Gastro-intestinal neoplastic lesions in Dex-treated SCID mice infected with one oocyst of C. parvum.
A. Invasive adenocarcinoma of the antropyloric region (arrows) in a mouse 100 days P.I.. Bar = 1250 µm (hematoxylin and eosin). B. Invasive adenocarcinoma of the antropyloric region in a mouse 100 days P.I. showing parasites inside the glands (arrows). Bar = 50 µm (hematoxylin and eosin). C. Adenoma of the ileo-caecal region in a mouse 45 days P.I.. Bar = 625 µm. D. High grade intraepithelial neoplasia in the ileo-caecal region in a mouse 45 days P.I. with numerous parasites (arrow) inside the glands. Bar = 25 µm (hematoxylin and eosin).

References

    1. Chen Z, Mi R, Yu H, Shi Y, Huang Y, et al. (2011) Prevalence of Cryptosporidium spp. in pigs in Shanghai, China. Vet Parasitol 181: 113–119.
    1. Ramirez NE, Ward LA, Sreevatsan S (2004) A review of the biology and epidemiology of cryptosporidiosis in humans and animals. Microbes Infect 6: 773–785.
    1. Yang R, Fenwick S, Potter A, Ng J, Ryan U (2011) Identification of novel Cryptosporidium genotypes in kangaroos from Western Australia. Vet Parasitol 179: 22–27.
    1. Chappell CL, Okhuysen PC, Langer-Curry R, Widmer G, Akiyoshi DE, et al. (2006) Cryptosporidium hominis: experimental challenge of healthy adults. Am J Trop Med Hyg 75: 851–857.
    1. Chappell CL, Okhuysen PC, Sterling CR, DuPont HL (1996) Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers. J Infect Dis 173: 232–236.
    1. Huang K, Akiyoshi DE, Feng X, Tzipori S (2003) Development of patent infection in immunosuppressed C57Bl/6 mice with a single Cryptosporidium meleagridis oocyst. J Parasitol 89: 620–622.
    1. Certad G, Ngouanesavanh T, Guyot K, Gantois N, Chassat T, et al. (2007) Cryptosporidium parvum, a potential cause of colic adenocarcinoma. Infect Agent Cancer 2: 22.
    1. Certad G, Creusy C, Ngouanesavanh T, Guyot K, Gantois N, et al. (2010) Development of Cryptosporidium parvum induced gastro-intestinal neoplasia in SCID mice: Severity of lesions is correlated with infection intensity. Am J Trop Med Hyg 82: 257–265.
    1. Certad G, Benamrouz S, Guyot K, Mouray A, Chassat T, et al. (2012) Fulminant cryptosporidiosis after near-drowning: a human Cryptosporidium parvum strain implicated in invasive gastrointestinal adenocarcinoma and cholangiocarcinoma in an experimental model. Appl Environ Microbiol 78: 1746–1751.
    1. Certad G, Creusy C, Guyot K, Mouray A, Chassat T, et al. (2010) Fulminant cryptosporidiosis associated with digestive adenocarcinoma in SCID mice infected with Cryptosporidium parvum TUM1 strain. Int J Parasitol 40 13: 1469–1475.
    1. Aliouat EM, Martinez A, Jimenez E, Dei-Cas E, Mullet C, et al. (1997) Development of pneumocystosis animal models: corticosteroid-treated Wistar rat; SCID mouse and nude rat. J Eukaryot Microbiol 44: 41S–42S.
    1. Guyot K, Gireaudot-Liepmann MF, Cabon A, Riveau-Ricard I, Lange M, et al. (2000) Influence of US Epa 1622 method successive steps on the viability of Cryptosporidium oocysts. Water Science & Technology 41: 189–196.
    1. Bulckaen H, Prévost G, Boulanger E, Robitaille G, Roquet V, et al. (2008) Low-dose aspirine prevents age-related endotheliall dysfunction in a mouse model of physiological aging. Am J Physiol Heart Circ Physiol 294: H1562–1570.
    1. Fontaine M, Guillot E (2002) Development of a TaqMan quantitative PCR assay specific for Cryptosporidium parvum . FEMS Microbiol Lett 214: 13–17.
    1. Yang S, Benson SK, Du C, Healey MC (2000) Infection of immunosuppressed C57BL/6N adult mice with a single oocyst of Cryptosporidium parvum . J Parasitol 86: 884–887.
    1. Huang K, Akiyoshi DE, Feng X, Tzipori S (2003) Development of patent infection in immunosuppressed C57Bl/6 mice with a single Cryptosporidium meleagridis oocyst. J Parasitol 89: 620–622.
    1. Aliouat-Denis CM, Chabé M, Demanche C, Aliouat eM, Viscogliosi E, et al. (2008) Pneumocystis species, co-evolution and pathogenic power. Infect Genet Evol 8: 708–726.
    1. Mahoney DF, Kerr JD, Goodger BV, Wright IG (1979) The immune response of cattle to Babesia bovis (syn. B. argentina). Studies on the nature and specificity of protection. Int J Parasitol 9: 297–306.
    1. Dolan TT, Young AS, Losos GJ, McMilian I, Minder CE (1984) Dose dependent responses of cattle to Theileria parva stabilate. Int J Parasitol 14: 89–95.
    1. Levine ND (1973) Protozoan Parasites of domestic animals and of man; edition S, editor. Minneapolis, MN: Burgess Publishing Company, 156–254.
    1. Rochelle PA, Marshall MM, Mead JR, Johnson AM, Korich DG, et al. (2002) Comparison of in vitro cell culture and a mouse assay for measuring infectivity of Cryptosporidium parvum . Appl Environ Microbiol 68: 3809–3817.
    1. Marcon GE, de Albuquerque DM, Batista AM, Andrade PD, Almeida EA, et al. (2011) Trypanosoma cruzi: parasite persistence in tissues in chronic chagasic Brazilian patients. Mem Inst Oswaldo Cruz 106: 85–91.
    1. Yoder JS, Beach MJ (2010) Cryptosporidium surveillance and risk factors in the United States. Exp Parasitol 124: 31–39.
    1. Haas CN, Rose JB (1994) Reconciliation of microbial risk models and outbreak epidemiology: the case of the Milwaukee outbreak. In: Proceeding of the 1994 Annual Conference: Water Works Assoc: 517–523.
    1. Shebl FM, Engels EA, Goedert JJ (2012) Opportunistic Intestinal Infections and Risk of Colorectal Cancer Among People with AIDS. AIDS Res Hum Retroviruses Epub ahead of print
    1. Sulżyc-Bielicka V, Kołodziejczyk L, Jaczewska S, Bielicki D, Kładny J, et al. (2012) Prevalence of Cryptosporidium sp. in patients with colorectal cancer. Pol Przegl Chir 84: 348–351.

Source: PubMed

3
Iratkozz fel